Grants and Contracts Details
| Status | Finished |
|---|---|
| Effective start/end date | 8/6/20 → 10/19/22 |
Funding
- Regeneron Pharmaceuticals: $21,744.00
A Phase 1/2 Study of REGN5093 in Patients with MET-Altered Advanced Non-Small Cell Lung Cancer
- Arnold, Susanne (PI)
| Status | Finished |
|---|---|
| Effective start/end date | 8/6/20 → 10/19/22 |